Contacted Congressional offices on the use of blood pathogen activation to respond to outbreaks of Ebola and Chikungunya, and to notify them about recent FDA approvals of Cerus blood products. H.R. 4870 / S.____, Department of Defense Appropriations Act, 2015, Titles IV and VI, all provisions related to blood pathogen inactivation and plasma.
HCR - Health Issues BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
INNOVATIVE FEDERAL STRATEGIES, LLC
511 C Street NE, Washington, DC, 20002, US
LETITIA WHITE DAVID FREDERICK KILIAN HEATHER MCNATT HENNESSEY LETITIA WHITE DAVID FREDERICK KILIAN HEATHER MCNATT HENNESSEY